Position in LLY
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$804,817
+$196,850 QoQ
Shares Held
671
+1.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#3,331
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026DELTA ASSET MANAGEMENT LLC/TN holds $27,667,664 across 14 Drug Manufacturers - General names. LLY ranks #6 (2.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
40,142 | $10,194,863 | |
| 2 | ABBV |
AbbVie Inc.
|
30,429 | $7,657,153 | |
| 3 | BMY |
Bristol Myers Squibb Co
|
75,264 | $4,336,711 | |
| 4 | PFE |
Pfizer Inc
|
105,462 | $2,539,524 | |
| 5 | MRK |
Merck & Co., Inc.
|
12,334 | $1,584,919 | |
| 6 | LLY |
ELI LILLY & Co
This page
|
671 | $804,817 | |
| 7 | AMGN |
Amgen Inc
|
999 | $361,757 | |
| 8 | GSK |
GSK plc
|
2,138 | $112,073 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $804,817 | 671 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $607,967 | 661 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $710,363 | 661 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $504,343 | 661 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $502,017 | 644 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $540,145 | 654 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $504,888 | 654 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $647,622 | 731 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $654,589 | 723 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $562,465 | 723 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $436,607 | 749 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $400,161 | 745 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $353,610 | 754 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $236,616 | 689 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $277,306 | 758 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $237,015 | 733 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $253,872 | 783 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $225,373 | 787 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $216,280 | 783 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $180,912 | 783 | Shares | Sole | 2021-11-03 | |
| 2021-06-30 | $179,714 | 783 | Shares | Sole | 2021-08-02 | |
| 2021-03-31 | $135,070 | 723 | Shares | Sole | 2021-04-28 | |
| 2020-12-31 | $122,071 | 723 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $107,018 | 723 | Shares | Sole | 2020-10-28 | |
| 2020-06-30 | $118,702 | 723 | Shares | Sole | 2020-07-23 | |
| 2020-03-31 | $103,762 | 748 | Shares | Sole | 2020-04-27 | |
| No filing history on record for this holder in this stock. | ||||||